Most efforts to fight cancer these days is either through chemicals such as those used in chemotherapy or via genetic engineering. In Japan, researchers went with the latter and used chickens as the tool. The scientists basically engineered poultry to lay eggs that will then be capable of fighting cancer as well as other types of diseases.
The new revolutionary method was performed by researchers at the National Institute of Advanced Industrial Science and Technology (AIST), which is located in the Osaka prefecture, The Japan News reports. Their project resulted in a hen laying eggs, which then contain pharmaceutical agents designed to fight certain illnesses such as cancer and hepatitis.
The researchers are planning on partnering with a research company to sell the drug, which might cut the costs of cancer drugs by as much as half the current price. It doesn’t stop there, either. The researchers are hoping that with this new method, the price of curing cancer will be reduced to a mere 10 percent of what it costs now. At least, this is what professor Hironobu Hojo of Osaka University said.
“This is a result that we hope leads to the development of cheap drugs,” Hojo said to The Japan News. “In the future, it will be necessary to closely examine the characteristics of the agents contained in the eggs and determine their safety as pharmaceutical products.”
The key to the drug lies in a type of protein, which is apparently effective at treating a particularly deadly kind of skin cancer, Futurism reports. This protein was then inserted into the eggs during the fertilization process. Eventually, the latest generation of eggs finally inherited the protein after several rounds of cross-breeding.
In essence, the researchers conducted artificial selection, which is something that gene-editing tools like CRISPR have made infinitely easier. This is just one example of how the future of medicine will be like.


Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Jensen Huang Urges Taiwan Suppliers to Boost AI Chip Production Amid Surging Demand
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
Oracle Plans $45–$50 Billion Funding Push in 2026 to Expand Cloud and AI Infrastructure
Palantir Stock Jumps After Strong Q4 Earnings Beat and Upbeat 2026 Revenue Forecast
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Instagram Outage Disrupts Thousands of U.S. Users
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Elon Musk’s SpaceX Acquires xAI in Historic Deal Uniting Space and Artificial Intelligence 



